The Composite Asthma Severity Index: A Tool for Assessing Impact of Omalizumab Treatment in Children with Moderate-to-Severe Persistent Allergic Asthma
Open Access
- 1 February 2018
- journal article
- abstracts
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 141 (2) , AB100